Skip to main
LNSR

LENSAR Inc (LNSR) Stock Forecast & Price Target

LENSAR Inc (LNSR) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

LENSAR is a commercial-stage medical device company with a strong market position in the femtosecond laser system market. With its advanced technologies and focus on providing better visual outcomes and efficiency, the company is well-positioned to continue its impressive top-line growth and potentially improve its bottom line in the future. The recent failed acquisition and spin-off from PDL BioPharma may have caused some uncertainty, but the company's strong financials and market share make it an attractive investment option.

Bears say

LENSAR is facing intense competition from larger, more established companies in the medical device industry, limiting its potential to gain significant market share in the laser cataract surgery market. Additionally, the company's changing ALLY pricing structure and seasonal revenue dynamics may result in instability and declining revenues over the next few years. Lastly, LENSAR's dependence on third-party manufacturers for its ALLY system poses a risk, as any disruptions or issues with these manufacturers could greatly affect the company's operations and financials.

LENSAR Inc (LNSR) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LENSAR Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LENSAR Inc (LNSR) Forecast

Analysts have given LENSAR Inc (LNSR) a Strong Buy based on their latest research and market trends.

According to 1 analysts, LENSAR Inc (LNSR) has a Strong Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LENSAR Inc (LNSR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.